Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: Cabaletta Bio Inc.
March 14, 2026
Cabaletta Bio Inc.
Orphan Drug Designation
treatment of pemphigus vulgaris
Disease Area:
Rare Diseases
Source
December 10, 2025
Cabaletta Bio Inc.
Orphan Drug Designation
FDA orphan drug designation: treatment of myasthenia gravis
Disease Area:
Rare Diseases
Source
Source
Scroll to Top
